1. Home
  2. CYTK vs LW Comparison

CYTK vs LW Comparison

Compare CYTK & LW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cytokinetics Incorporated

CYTK

Cytokinetics Incorporated

HOLD

Current Price

$61.52

Market Cap

7.6B

Sector

Health Care

ML Signal

HOLD

Logo Lamb Weston Holdings Inc.

LW

Lamb Weston Holdings Inc.

HOLD

Current Price

$40.09

Market Cap

7.0B

ML Signal

HOLD

Company Overview

Basic Information
Metric
CYTK
LW
Founded
1997
1950
Country
United States
United States
Employees
N/A
10100
Industry
Biotechnology: Pharmaceutical Preparations
Packaged Foods
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
7.6B
7.0B
IPO Year
2004
2016

Fundamental Metrics

Financial Performance
Metric
CYTK
LW
Price
$61.52
$40.09
Analyst Decision
Strong Buy
Buy
Analyst Count
18
7
Target Price
$88.50
$56.14
AVG Volume (30 Days)
1.8M
2.2M
Earning Date
05-05-2026
04-01-2026
Dividend Yield
N/A
3.74%
EPS Growth
N/A
N/A
EPS
N/A
0.90
Revenue
$13,368,000.00
N/A
Revenue This Year
$8.73
$4.23
Revenue Next Year
$309.93
N/A
P/E Ratio
N/A
$45.12
Revenue Growth
N/A
N/A
52 Week Low
$29.31
$39.69
52 Week High
$70.98
$67.07

Technical Indicators

Market Signals
Indicator
CYTK
LW
Relative Strength Index (RSI) 45.86 30.08
Support Level $59.13 $39.79
Resistance Level $65.72 $57.57
Average True Range (ATR) 2.57 1.42
MACD 0.03 -0.50
Stochastic Oscillator 49.44 5.91

Price Performance

Historical Comparison
CYTK
LW

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

About LW Lamb Weston Holdings Inc.

Lamb Weston is North America's largest and the world's second-largest producer of branded and private-label frozen potato products, both by volume and value. The company's portfolio is anchored by french fries, but it also sells sweet potato fries, tater tots, diced potatoes, mashed potatoes, hash browns, and chips. Roughly two thirds of revenue comes from its home market of North America, with none of the other 100 countries the company sells into representing a significant share. McDonald's is Lamb Weston's single-largest customer at 15% of fiscal 2025 sales, with no other company representing more than 10%. Lamb Weston became an independent company in 2016 when it was spun off from Conagra.

Share on Social Networks: